Trial Profile
Measurement of renal function with new equation and clinical implications in multiple myeloma patients receiving lenalidomide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 13 Sep 2017 New trial record